Navigation Links
Pharmaco in Zambia Scrutinizes the Side Effects of Medicines Launched In the Market

A new vigilant body was set up by the Zambia Pharmaceutical Regulatory Authority (PRA). The main purpose of this body is to monitor the safety of medicines during the post marketing// surveillance process. Pharmaco, as the monitoring body is named would supervise all adverse reactions due to a particular drug. This is to inculcate in people the rational use of medicines. The acting Health Minister Ronnie Shikapwasha launched the body on the 16th of June said that this unit would efficiently perform the job allotted to it. He also said that this was launched as adverse effects of all drugs that hit the market are not known before the medicine is marketed.

Hence this body would create awareness among he public. He said that in the recent years there was an increase in the use of medicine for HIV/AIDS, malaria and tuberculosis and hence there was a need for the monitoring unit. These drugs were new to the market and sufficient safety data was not available. This led to the development of a monitoring system which would study the effects of the drugs, documenting drug resistance patterns and treatment failures of both conventional and new medicines. In conclusion this would always keep the public as well as the medical community posted about the medicines in the market.


'"/>




Page: 1

Related medicine news :

1. India, US Pharmacopoeia Signs Mou to Promote Awareness About Medicines
2. Herbal remedies to be tested by Zambia for AIDS treatment
3. Bird Flu In Zambia-Panic Among Locals
4. Zambia Struggling To Identify AIDS Sufferers
5. The Aids Programme In Zambia Reported As A Success
6. PEPFAR to help Zambias efforts to fight AIDS
7. Acupuncture May Help Chemotherapy Side Effects
8. Chemotherapy Pill Has Fewer Side Effects Than IV
9. Therapy Boosts Chemotherapy Effects
10. Smoking and its Effects
11. Reducing The After Effects of Tonsillectomy
Post Your Comments:
(Date:12/2/2008)... , Romantic relationships establish special bonds...leads to permanent partnerships, and ultimately, t...or both partners place too much emotional weight o...y tend to evaluate their self-worth solely based o...s is what psychologists term as relationship-conti...
(Date:12/2/2008)... CHICAGO, Dec. 2 Breast-Specific ...ly sensitive imaging technique for the diagnosis o...o diagnose breast cancer. BSGI,is a molecular bre...dent of,tissue density and discover very early st...ound and magnetic resonance imaging (MRI), BSGI ha...
(Date:12/2/2008)... WASHINGTON, Dec. 2 In...merican Association of Homes and Services for the ... offered four ways that the Obama administration c...m solutions to the way America cares for its most ...clude: , Expand the Nation,s Work Force: Creat...
(Date:12/2/2008)... DETROIT, Dec. 2 Toda... organizations, elected officials and other commun...eighborhoods in Detroit/Wayne County to solidify p...tory, culture and economic successes and challenge...our is part of the opening session of a three-day ...
Breaking Medicine News(10 mins):Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 3
...n the heels of the outrage over an insensitive cap...urne in Australia, comes the news that a pre-scho...apanese hospital for unwanted babies. The drop-of...Hospital in the southern city of Kumamoto to disco...
...gh degree of trust and confidence in doctors refle...this survey reflects the immense efforts from doc... for their patients despite the financial pressure...n virtually all of the questions patients were ask...
...ng to University of Illinois food science and huma...cts may be healthy additions to a persons diet , a...y, or even cancer-causing agents. Helferich has s...effects of isoflavones, a class of plant estrogens...
...hers at the University of Wisconsin-Madison have d...uring molecular structures quickly and accurately...ee the shapes of intermediate steps. And what has...at the first applications of the technique offer a...
Other Medicine News:Health News:Three-year-old Abandoned in Box Meant for Unwanted Babies in Japan 2Health News:Soy Products a Double-edged Sword for Breast Cancer 2Health News:Soy Products a Double-edged Sword for Breast Cancer 3Health News:New Analytical Tool to Unravel the Cause of Diabetes 2
(Date:12/1/2008).../ -- Vical Incorporated (Nasdaq: VICL ) announce...yment from Merck & Co., Inc. based on Merck,s ...an investigational plasmid DNA (pDNA) cancer vacci...gene delivery technology and encodes human telomer...bject of separate license agreement. , , "T...
(Date:11/27/2008)...ymphoblastic leukemia relapse cases arise from a c... , MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNewswi...Hospital have identified distinctive genetic chang...hoblastic leukemia (ALL) that cause relapse. The f...r ALL relapse in children and, ultimately, in adul...
(Date:11/25/2008)...Newswire/ -- Kleinert Kutz and University of Loui...d transplant on Messina, New York resident, Jan "E...d Care Center on Monday, November 24. The innovat...shortly after 9 p.m. in a record nine hours. , ...h/20081125/DC48555-a ) , (Photo: http://www.n...
(Date:11/25/2008)... to Assess Survival of Patients Receiving Litx ver...patocellular Carcinoma , , BELLEVUE, Wash.,...Inc. (LSO) today announced the completion of enrol...Infusion Therapy(TM) (Litx(TM)) as a treatment for... known as hepatoma or primary liver cancer. , ...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 1Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 4Clot Busting Treatment Improves Bleeding Stroke Outcomes 19289 1Clot Busting Treatment Improves Bleeding Stroke Outcomes 19289 2Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 1Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 2Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 3Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 4Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 5FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 1FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 2FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 3FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 4FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 5FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 6FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 7FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 8FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 9
...N, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarmi...of CANCER (a peer-reviewed,journal of the American...taking the standard five-year regimen of the hormo...continue therapy early.(1), According to the autho...or issue that may negatively affect treatment effi...
...LPHIA, March 15, 2007-- The cause of one notorious...reat the ongoing,threat of another childhood disea... Research, researchers from Stony Brook University...orm of poliovirus,is effective in obliterating neu...been previously vaccinated against the virus. , By...
Other Medicine Technology:One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
Medicine Products: